Skip to main content

CITADEL ADVISORS LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in VTGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Mar 31, 2026
CallValue
$136,344
CallShares
239,200
PutValue
$20,349
PutShares
35,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in VTGN

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,349 35,700
2026-03-31 $136,344 239,200
2025-12-31 $306,966 465,100
2025-12-31 $255,156 386,600
2025-09-30 $353,225 99,500
2025-09-30 $861,230 242,600
2025-09-30 $433,320 122,062
2025-06-30 $71,800 35,900
2025-06-30 $134,200 67,100
2025-03-31 $3,000 1,200
2025-03-31 $22,250 8,900
2024-12-31 $161,070 54,600
2024-12-31 $33,040 11,200
2024-09-30 $167,055 55,500
2024-09-30 $968,873 321,885
2024-09-30 $42,140 14,000
2024-06-30 $164,256 47,200
2024-06-30 $100,224 28,800
2024-06-30 $2,191,164 629,645
2024-03-31 $3,927,897 743,920
2024-03-31 $278,784 52,800
2024-03-31 $126,192 23,900
2023-12-31 $198,918 38,700
2023-12-31 $179,386 34,900
2023-12-31 $3,821,564 743,495
2023-09-30 $44,812 8,552
2023-09-30 $262,000 50,000
2023-09-30 $51,352 9,800
2023-06-30 $37,158 19,871